Skip to content


Biorphen, Phenylephrine, Vazculep, Omidria (phenylephrine) is a small molecule pharmaceutical. Phenylephrine was first approved as Biorphen on 2012-12-20. It is used to treat fissure in ano, hemorrhoids, hypotension, open-angle glaucoma, and pruritus ani amongst others in the USA. It has been approved in Europe to treat intraocular lens implantation and postoperative pain. The pharmaceutical is active against alpha-1A adrenergic receptor and alpha-1B adrenergic receptor. In addition, it is known to target alpha-1D adrenergic receptor. Cold relief multi-symptom's patent is valid until 2033-11-14 (FDA).
Trade Name Omidria
Common Name Phenylephrine
Indication fissure in ano, hemorrhoids, hypotension, intraocular lens implantation, open-angle glaucoma, postoperative pain, pruritus ani, septic shock, supraventricular tachycardia, vasomotor rhinitis
Drug Class
Get full access now